Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Lonn EM, Bosch J, López-Jaramillo P, Zhu J, Liu L, Pais P, Diaz R, Xavier D, Sliwa K, Dans A, Avezum A, Piegas LS, Keltai K, Keltai M, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Parkhomenko A, Khunti K, Toff WD, Reid CM, Varigos J, Leiter LA, Molina DI, McKelvie R, Pogue J, Wilkinson J, Jung H, Dagenais G, Yusuf S; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2009-20. doi: 10.1056/NEJMoa1600175. Epub 2016 Apr 2.

2.

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Yusuf S, Bosch J, Dagenais G, Zhu J, Xavier D, Liu L, Pais P, López-Jaramillo P, Leiter LA, Dans A, Avezum A, Piegas LS, Parkhomenko A, Keltai K, Keltai M, Sliwa K, Peters RJ, Held C, Chazova I, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Sanchez-Vallejo G, McKelvie R, Pogue J, Jung H, Gao P, Diaz R, Lonn E; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2021-31. doi: 10.1056/NEJMoa1600176. Epub 2016 Apr 2.

3.

Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.

Yusuf S, Lonn E, Pais P, Bosch J, López-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, Parkhomenko A, Keltai M, Keltai K, Sliwa K, Chazova I, Peters RJ, Held C, Yusoff K, Lewis BS, Jansky P, Khunti K, Toff WD, Reid CM, Varigos J, Accini JL, McKelvie R, Pogue J, Jung H, Liu L, Diaz R, Dans A, Dagenais G; HOPE-3 Investigators.

N Engl J Med. 2016 May 26;374(21):2032-43. doi: 10.1056/NEJMoa1600177. Epub 2016 Apr 2.

4.

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators.

N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15.

5.

Ivabradine in stable coronary artery disease without clinical heart failure.

Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R; SIGNIFY Investigators.

N Engl J Med. 2014 Sep 18;371(12):1091-9. doi: 10.1056/NEJMoa1406430. Epub 2014 Aug 31.

6.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
7.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

8.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators.

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

9.

[Coronary reserve peculiarities in patients with ischemic heart diseases depending on gender and age aspects].

Tashchuk VK, Ilashchuk TO, Hrechko SI, Polishchuk OIu, Turubarova-Leunova NA, Ivanchuk PR, Polians'ka OS.

Lik Sprava. 2010 Oct-Dec;(7-8):33-8. Ukrainian.

PMID:
21714284
10.

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.

Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L; SHIFT Investigators.

Lancet. 2010 Sep 11;376(9744):875-85. doi: 10.1016/S0140-6736(10)61198-1. Erratum in: Lancet. 2010 Dec 11;376(9757):1988. Lajnscak, M [corrected to Lainscak, M]; Rabanedo, I Roldan [corrected to Rabadán, I Roldan]; Leva, M [corrected to Ieva, M].

PMID:
20801500
11.

[Coronary reserve features in patients with ischemic heart disease regarding sex and age aspects].

Tashchuk VK, Ilashchuk TO, Hrechko SI, Polishchuk OIu, Turubarova-Leunova NA, Ivanchuk PR, Polians'ka OS.

Lik Sprava. 2009 Oct-Dec;(7-8):41-5. Ukrainian.

PMID:
20455446
12.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
14.

[The chronobiological conception of the development of acute myocardial infarction].

Pishak VP, Tashchuk VK, Ilashchuk TA.

Klin Med (Mosk). 2007;85(9):38-40. Russian.

PMID:
18038565
15.

[Effect of angiotensin receptor blockers on hemodynamic aspects during myocardial infarction].

Turubarova NA, Leunov VV, Tashchuk VK.

Lik Sprava. 2002 Apr-Jun;(3-4):43-4. Ukrainian.

PMID:
12145889
16.

[Enalapril and irbesartan in treatment of patients with arterial hypertension].

Tashchuk VK, Ilashchuk TO.

Lik Sprava. 2002 Apr-Jun;(3-4):114-6. Ukrainian.

PMID:
12145874
17.

[Some specific indices for stress tests in patients with ischemic heart disease concurrent with chronic cholecystitis].

Tashchuk VK, Trefanenko IV, Polishchuk OIu.

Lik Sprava. 2001 May-Jun;(3):27-9. Ukrainian.

PMID:
11560019
18.

[The characteristics of the realization of myocardial ischemia as dependent on stress test results in women with myocardial lesions of various origins].

Tashchuk VK, Hrechko SI, Polishchuk OIu, Makoviĭchuk IO, Turubarova NA, el-Telbani A, Chaplyns'kyĭ RV, Sokur IV.

Lik Sprava. 1998 Dec;(8):55-7. Ukrainian.

PMID:
10204349
19.

[The objective assessment of treatment efficacy in microfocal myocardial infarct using paired stress tests].

Tashchuk VK, Polishchuk OIu, Hrechko SI, Makoviĭchuk IO, Polians'ka OS, Turubarova NA, Chaplyns'kyĭ RB, Sokur IV.

Lik Sprava. 1998 Aug;(6):84-6. Ukrainian. No abstract available.

PMID:
9844883
20.

[The treatment of chronic ischemic heart disease: the potentials for hypolipidemic correction using current drugs].

Tashchuk VK, Makoviĭchuk IO, Bilets'kyĭ SV, Hrechko SI, Polishchuk OIu, Turubarova NA.

Lik Sprava. 1998 Jul-Aug;(5):101-3. Ukrainian.

PMID:
9793321

Supplemental Content

Loading ...
Support Center